Effects of Statin Use for Primary Prevention among Adults Aged 75 Years and Older in the National Health Insurance Service Senior Cohort (2002–2015)
Sunyoung Kim, Hangseok Choi, Chang Won Won
Ann Geriatr Med Res. 2020;24(2):91-98.   Published online 2020 Jun 29     DOI: https://doi.org/10.4235/agmr.20.0028
Citations to this article as recorded by Crossref logo
Moderate-intensity statin use for primary prevention for more than 5 years is associated with decreased all-cause mortality in 75 years and older
Sunyoung Kim, Hangseok Choi, Chang Won Won
Archives of Gerontology and Geriatrics.2022; 100: 104644.     CrossRef
Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies
Kamal Awad, Maged Mohammed, Mahmoud Mohamed Zaki, Abdelrahman I. Abushouk, Gregory Y. H. Lip, Michael J. Blaha, Carl J. Lavie, Peter P. Toth, J. Wouter Jukema, Naveed Sattar, Maciej Banach
BMC Medicine.2021;[Epub]     CrossRef
Impact of Prior Statin Use on Reperfusion Rate and Stroke Outcomes in Patients Receiving Endovascular Treatment
Sang-Hwa Lee, Min Uk Jang, Yerim Kim, So Young Park, Chulho Kim, Yeo Jin Kim, Jong-Hee Sohn
Journal of Clinical Medicine.2021; 10(21): 5147.     CrossRef
Aspirin and statin therapy for primary prevention of cardiovascular disease in older adults
Sophie Montgomery, Michael D Miedema, John A Dodson
Heart.2021; : heartjnl-2021-320154.     CrossRef